Targeting Ca<sup>2+</sup> Signaling in the Initiation, Promotion and Progression of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is a considerable health burden worldwide and a major contributor to cancer-related deaths. HCC is often not noticed until at an advanced stage where treatment options are limited and current systemic drugs can usually only prolong survival for a short time. Understand...
Main Authors: | Eunus S. Ali, Grigori Y. Rychkov, Greg J. Barritt |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/10/2755 |
Similar Items
-
TRPM2 Non-Selective Cation Channels in Liver Injury Mediated by Reactive Oxygen Species
by: Eunus S. Ali, et al.
Published: (2021-08-01) -
Sinularin, an Anti-Cancer Agent Causing Mitochondria-Modulated Apoptosis and Cytoskeleton Disruption in Human Hepatocellular Carcinoma
by: Chou-Yuan Ko, et al.
Published: (2021-04-01) -
Blockage of Store-Operated Ca<sup>2+</sup> Influx by Synta66 is Mediated by Direct Inhibition of the Ca<sup>2+</sup> Selective Orai1 Pore
by: Linda Waldherr, et al.
Published: (2020-10-01) -
Store-Operated Ca<sup>2+</sup> Entry in Tumor Progression: From Molecular Mechanisms to Clinical Implications
by: Yih-Fung Chen, et al.
Published: (2019-06-01) -
Role of Ca<sup>2+</sup> in Mediating Plant Responses to Extracellular ATP and ADP
by: Greg Clark, et al.
Published: (2018-11-01)